Adult Bone Marrow Cell Therapy for Ischemic Heart Disease: Evidence and Insights From Randomized Controlled Trials
about
Pathological Left Ventricular Hypertrophy and Stem Cells: Current Evidence and New PerspectivesCell Size Critically Determines Initial Retention of Bone Marrow Mononuclear Cells in the Heart after Intracoronary Injection: Evidence from a Rat ModelStem cell therapy for chronic ischaemic heart disease and congestive heart failure.Meta-Analysis of Preclinical Data Reveals Efficacy of Cardiac Stem Cell Therapy for Heart Repair.p53 Modulates the Fate of Cardiac Progenitor Cells Ex Vivo and in the Diabetic Heart In Vivo.Novel therapeutic strategies targeting fibroblasts and fibrosis in heart disease.Bone Marrow Mononuclear Cell Transplantation Restores Inflammatory Balance of Cytokines after ST Segment Elevation Myocardial Infarction.Biomaterial strategies to improve the efficacy of bone marrow cell therapy for myocardial infarction.Long-Term Outcome of Combined (Percutaneous Intramyocardial and Intracoronary) Application of Autologous Bone Marrow Mononuclear Cells Post Myocardial Infarction: The 5-Year MYSTAR StudyRational transplant timing and dose of mesenchymal stromal cells in patients with acute myocardial infarction: a meta-analysis of randomized controlled trials.iPSC-derived human cardiac progenitor cells improve ventricular remodelling via angiogenesis and interstitial networking of infarcted myocardium.Meta-Analyses of Human Cell-Based Cardiac Regeneration Therapies: Controversies in Meta-Analyses Results on Cardiac Cell-Based Regenerative Studies.A Large-Scale Investigation of Hypoxia-Preconditioned Allogeneic Mesenchymal Stem Cells for Myocardial Repair in Nonhuman Primates: Paracrine Activity Without Remuscularization.Position Paper of the European Society of Cardiology Working Group Cellular Biology of the Heart: cell-based therapies for myocardial repair and regeneration in ischemic heart disease and heart failure.Implantation of a Poly-L-Lactide GCSF-Functionalized Scaffold in a Model of Chronic Myocardial InfarctionInhibition of Histone Methyltransferase, Histone Deacetylase, and β-Catenin Synergistically Enhance the Cardiac Potential of Bone Marrow Cells.Oxidative stress in mesenchymal stem cell senescence: regulation by coding and non-coding RNAs.Cell therapy for heart disease: Trial sequential analyses of two Cochrane reviews.Prospect of ultrasound-mediated gene delivery in cardiovascular applications.New strategies for improving stem cell therapy in ischemic heart disease.Improving stem cell therapy in cardiovascular diseases: the potential role of microRNA.Concise Review: Perspectives and Clinical Implications of Bone Marrow and Circulating Stem Cell Defects in Diabetes.Biomaterial-Enhanced Cell and Drug Delivery: Lessons Learned in the Cardiac Field and Future Perspectives.Clinical efficacy and safety of autologous stem cell transplantation for patients with ST-segment elevation myocardial infarction.Can the outcomes of mesenchymal stem cell-based therapy for myocardial infarction be improved? Providing weapons and armour to cells.Concise Review: Mending a Broken Heart: The Evolution of Biological Therapeutics.Bone Marrow-Derived Progenitor Cells Are Functionally Impaired in Ischemic Heart Disease.Cardiac Stem Cells for Myocardial Regeneration: They Are Not Alone.Allogenic adipose-derived stem cell therapy overcomes ischemia-induced microvessel rarefaction in the myocardium: systems biology study.Mesenchymal stromal cell therapy as treatment for ischemic heart failure: the MSC-HF study.Mesenchymal stem cells suppress cardiac alternans by activation of PI3K mediated nitroso-redox pathway.The modest outcome of clinical trials with bone marrow cells for myocardial repair: is the autologous source of cells the prime culprit?Allogeneic Precursor Cells for Systolic Heart Failure: A Need for Mechanisms in Humans.Preconditioning with far-infrared irradiation enhances proliferation, cell survival, and migration of rat bone marrow-derived stem cells via CXCR4-ERK pathwaysOCT4 expression mediates partial cardiomyocyte reprogramming of mesenchymal stromal cells.Left Atrial Appendage characteristics in patients with Persistent Atrial Fibrillation undergoing catheter ablation (LAAPAF Study).Short- and long-term outcomes of intramyocardial implantation of autologous bone marrow-derived cells for the treatment of ischaemic heart disease.Induced Pluripotent Stem Cell (iPSC)-Derived Extracellular Vesicles Are Safer and More Effective for Cardiac Repair than iPSCs.Implantation of a Novel Allogeneic Mesenchymal Precursor Cell Type in Patients with Ischemic Cardiomyopathy Undergoing Coronary Artery Bypass Grafting: an Open Label Phase IIa Trial.What Is the Future of Cell-Based Therapy for Acute Myocardial Infarction.
P2860
Q26769997-0712A8F8-41A8-41C0-8AA9-01BD66D0333BQ28552343-8A6E1656-4DB0-4185-B799-BE918BAF9C34Q30239945-D7662653-4A16-4937-A468-2C7F5AA93424Q31077728-FEDD3CA7-3686-4AD2-BCE5-91987CDC5E3FQ33809750-64ECC4E6-1E32-465C-B309-9F6730AED7DEQ34531894-DD87425A-F3E4-4856-94A0-6D8FC9AEF97AQ35874397-11859B9A-6A66-41F6-AB57-524CAD9355DDQ36127860-B9DE0002-AF94-470B-9090-59C5069280B4Q36169198-07D02C55-0E41-4090-88C3-2764B06473FBQ36262927-D43433A9-A5ED-49B6-BE36-69ADFD6ED524Q36504336-9B6807B4-4317-421D-BCDB-A8D17E2E037EQ36807360-F0937FDE-C093-4602-A190-923F1DDC0A86Q36973427-42DCDB29-1622-4179-9DC1-4AD2DEE9B1F9Q37016190-C982891D-8996-4833-8BC7-976D2D15F4DBQ37662785-3EBAAEF6-6018-4508-9A88-5D0B9283EFD8Q38633015-5DFBA2B2-95E8-42C0-BDF3-1B09D65B5F25Q38648719-0B360E11-1CCA-4E20-82D5-57DF8C2A0774Q38714410-A519E731-F0C2-4447-A05C-4105315C2844Q38803772-1F54D6E6-EE24-4AA7-B70E-CF9412831F93Q38804978-AF9B7791-CA63-4E28-BA39-4B28D1244E67Q38840533-4261F2C5-5028-437C-A96D-B9BBC9761E61Q38843000-36AB73A9-3FCA-455E-A7E1-F584C088243AQ38912627-0132E920-33B1-4071-A479-2EF48F3A3DB5Q38930553-3CA00BFE-CBE9-439C-8F86-E8A357AAF415Q39017865-5EADB40B-F560-43C3-93FD-5692C5B045E7Q39149000-519181AE-F865-4DFC-B1BF-951108AFEC6CQ40600315-28A11256-50AB-46C5-86E2-F2CD6A00057CQ41024149-EFE647CC-CFC5-4114-87FD-AF9C1CBC69E5Q41997489-1FD4CA20-DE41-4E0C-9F8A-95AEA27BBC6DQ42333634-E2318322-CA37-471C-8C73-A647F03F4804Q42353140-3FD9320F-0F86-4535-B144-910A188DDEE1Q42369312-09D6F699-75F3-4DEC-A655-55A69268E1D8Q42641725-6710837B-47A5-45C4-957B-B78FFDE16D0EQ42652495-1822363E-FEE4-45F9-9205-349B10A011BBQ47101037-9AC23A4E-C519-448E-A2AD-7424FB033C37Q47162551-F1BBBED7-DBAE-41EE-9B9F-31376B39A639Q47347279-2645AACB-B15D-45E2-A905-41040E058771Q47423939-296E3D9A-6147-4C4D-937E-74B344F89469Q47783627-FBC85A56-7429-40B6-84CF-8C16B44BCCFFQ48062986-16A17106-270C-4B87-9FDC-FB95E9CE4994
P2860
Adult Bone Marrow Cell Therapy for Ischemic Heart Disease: Evidence and Insights From Randomized Controlled Trials
description
2015 nî lūn-bûn
@nan
2015 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Adult Bone Marrow Cell Therapy ...... m Randomized Controlled Trials
@ast
Adult Bone Marrow Cell Therapy ...... m Randomized Controlled Trials
@en
Adult Bone Marrow Cell Therapy ...... m Randomized Controlled Trials
@nl
type
label
Adult Bone Marrow Cell Therapy ...... m Randomized Controlled Trials
@ast
Adult Bone Marrow Cell Therapy ...... m Randomized Controlled Trials
@en
Adult Bone Marrow Cell Therapy ...... m Randomized Controlled Trials
@nl
prefLabel
Adult Bone Marrow Cell Therapy ...... m Randomized Controlled Trials
@ast
Adult Bone Marrow Cell Therapy ...... m Randomized Controlled Trials
@en
Adult Bone Marrow Cell Therapy ...... m Randomized Controlled Trials
@nl
P2093
P2860
P3181
P1433
P1476
Adult Bone Marrow Cell Therapy ...... m Randomized Controlled Trials
@en
P2093
Anweshan Samanta
Buddhadeb Dawn
Muhammad R Afzal
Vinodh Jeevanantham
Zubair I Shah
P2860
P304
P3181
P356
10.1161/CIRCRESAHA.114.304792
P407
P577
2015-07-09T00:00:00Z